These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 849647)

  • 1. A second case of human C3b inhibitor (KAF) deficiency.
    Thompson RA; Lachmann PJ
    Clin Exp Immunol; 1977 Jan; 27(1):23-9. PubMed ID: 849647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of C3b inactivator (KAF) concentration on the ability of serum to support complement activation.
    Lachmann PJ; Halbwachs L
    Clin Exp Immunol; 1975 Jul; 21(1):109-14. PubMed ID: 52423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete absence of the third component of complement in man.
    Ballow M; Shira JE; Harden L; Yang SY; Day NK
    J Clin Invest; 1975 Sep; 56(3):703-10. PubMed ID: 1159084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies in vivo and in vitro on an abnormality in the metabolism of C3 in a patient with increased susceptibility to infection.
    Alper CA; Abramson N; Johnston RB; Jandl JH; Rosen FS
    J Clin Invest; 1970 Nov; 49(11):1975-85. PubMed ID: 4097977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A family with partial and total deficiency of complement C3.
    Grace HJ; Brereton-Stiles GG; Vos GH; Schonland M
    S Afr Med J; 1976 Jan; 50(5):139-40. PubMed ID: 1251291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [An exceptional component C3 deficiency revealed by serum protein electrophoresis].
    Dejoie T; Audrain M; Bach-Ngohou K; Denis M; Legoue-Morillon S; Thomas C; Masson D
    Ann Biol Clin (Paris); 2009; 67(6):715-9. PubMed ID: 19939777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C3 metabolism in a patient with deficiency of the second component of complement (C2) and discoid lupus erythematosus.
    Wild JH; Zvaifler NJ; Müller-Eberhard HJ; Wilson CB
    Clin Exp Immunol; 1976 May; 24(2):238-48. PubMed ID: 1084239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chemotaxis defect and recurrent E. coli meningitis].
    Herpertz B; Burdach SE; Rister M
    Monatsschr Kinderheilkd; 1985 Feb; 133(2):82-5. PubMed ID: 3885013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C3b inactivator deficiency with immune complex manifestations.
    Solal-Celigny P; Laviolette M; Hebert J; Atkins PC; Sirois M; Brun G; Lehner-Netsch G; Delâge JM
    Clin Exp Immunol; 1982 Jan; 47(1):197-205. PubMed ID: 7094424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary deficiency of the seventh component of complement.
    Boyer JT; Gall EP; Norman ME; Nilsson UR; Zimmerman TS
    J Clin Invest; 1975 Oct; 56(4):905-13. PubMed ID: 1099121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement components and receptors: deficiencies and disease associations.
    Bartholomew WR; Shanahan TC
    Immunol Ser; 1990; 52():33-51. PubMed ID: 2091785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlations between serum factor B and C3b inactivator levels in normal subjects and in patients with infections, nephrosis and hypocomplementaemic glomerulonephritis.
    Forristal J; Iitaka K; Vallota EH; West CD
    Clin Exp Immunol; 1977 Apr; 28(1):61-71. PubMed ID: 862250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement deficiency states and infection: epidemiology, pathogenesis and consequences of neisserial and other infections in an immune deficiency.
    Ross SC; Densen P
    Medicine (Baltimore); 1984 Sep; 63(5):243-73. PubMed ID: 6433145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent meningitis in a patient with congenital deficiency of the C9 component of complement. First case of C9 deficiency in Europe.
    Zoppi M; Weiss M; Nydegger UE; Hess T; Späth PJ
    Arch Intern Med; 1990 Nov; 150(11):2395-9. PubMed ID: 2241452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homozygous human C3 deficiency. The role of C3 in antibody production, C-1s-induced vasopermeability, and cobra venom-induced passive hemolysis.
    Alper CA; Colten HR; Gear JS; Rabson AR; Rosen FS
    J Clin Invest; 1976 Jan; 57(1):222-9. PubMed ID: 1107355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complementing the patient: a complement component deficiency in a patient with recurrent infections and glomerulonephritis.
    Sinclair D; Wilde G; Bex S; Peters S
    Clin Lab; 2005; 51(9-10):505-7. PubMed ID: 16285472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hereditary complement deficiencies].
    Fischer E
    Hautarzt; 1982 Feb; 33(2):65-72. PubMed ID: 6281215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for complement deficiencies in unselected patients with meningitis.
    Rasmussen JM; Brandslund I; Teisner B; Isager H; Svehag SE; Maarup L; Willumsen L; Rønne-Rasmussen JO; Permin H; Andersen PL
    Clin Exp Immunol; 1987 May; 68(2):437-45. PubMed ID: 3498576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical study of congenital complement deficiencies and abnormalities].
    Inai S
    Nihon Rinsho; 1988 Sep; 46(9):2011-6. PubMed ID: 3241391
    [No Abstract]   [Full Text] [Related]  

  • 20. Introduction: complement diseases in man.
    Miller ME
    Birth Defects Orig Artic Ser; 1975; 11(1):299-300. PubMed ID: 1148384
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.